Heberprot-p, Reaches Slovakia, First Stop in the European Union

Posted on Posted in Sin categoría
Compartir/ShareShare on FacebookTweet about this on Twitter

Havana, May 24.- A delegation of Cuban doctors arrived in Slovakia to bring advisory in the application of Heberprot-p, the only drug in the world for the treatment of diabetic foot, reported today CubaMinrex foreign Ministry’s website.

The note highlighted that Slovakia will be the first country of the European Union where the injection, made by the Center of Genetic Engineering and Biotechnology has been in the market for almost a decade.

Data from the National Center for Medical Information also specify that more than 8,000 people suffer from this disease in the European nation.

The director of the Health Ministry, Boris Bánovsky, said that the purpose is to offer Slovak patients a modern, special treatment, which can help them to cure the disease and increase their quality of life.

The purpose is that as many patients as possible, who meet the indicative requirements, receive the treatment, he highlighted.

According to a note from the Cuban embassy, the Slovak Heath Ministry prepared the necessary information materials for treatments in specialized medical consultations.

After its release, El Heberprot-P has managed to cure a quarter of a million people in the world, after its registering in more than 20 nations, according to figures from Cuban health authorities.

The injection, which accelerates the healing of lesions and reduces the risk of amputation of lower limbs in almost 80 percent of cases, has a patent awarded the gold medal of the World Intellectual Property Organization.